These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28007600)

  • 1. Sox9 mediated transcriptional activation of FOXK2 is critical for colorectal cancer cells proliferation.
    Qian Y; Xia S; Feng Z
    Biochem Biophys Res Commun; 2017 Jan; 483(1):475-481. PubMed ID: 28007600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
    Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
    Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
    [No Abstract]   [Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
    Panza A; Votino C; Gentile A; Valvano MR; Colangelo T; Pancione M; Micale L; Merla G; Andriulli A; Sabatino L; Vinciguerra M; Prattichizzo C; Mazzoccoli G; Colantuoni V; Piepoli A
    Biochim Biophys Acta; 2014 Jun; 1843(6):1225-36. PubMed ID: 24631504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foxk2 inhibits non-small cell lung cancer epithelial-mesenchymal transition and proliferation through the repression of different key target genes.
    Chen S; Jiang S; Hu F; Xu Y; Wang T; Mei Q
    Oncol Rep; 2017 Apr; 37(4):2335-2347. PubMed ID: 28260088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of FOXK2 is associated with poor prognosis in patients with gastric cancer.
    Liu X; Wei X; Niu W; Wang D; Wang B; Zhuang H
    Mol Med Rep; 2018 Nov; 18(5):4356-4364. PubMed ID: 30221666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer.
    Panza A; Pazienza V; Ripoli M; Benegiamo G; Gentile A; Valvano MR; Augello B; Merla G; Prattichizzo C; Tavano F; Ranieri E; di Sebastiano P; Vinciguerra M; Andriulli A; Mazzoccoli G; Piepoli A
    Biochim Biophys Acta; 2013 Aug; 1833(8):1853-65. PubMed ID: 23583560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Context-specific role of SOX9 in NF-Y mediated gene regulation in colorectal cancer cells.
    Shi Z; Chiang CI; Labhart P; Zhao Y; Yang J; Mistretta TA; Henning SJ; Maity SN; Mori-Akiyama Y
    Nucleic Acids Res; 2015 Jul; 43(13):6257-69. PubMed ID: 26040697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dose-dependent effect of SOX9 and its incidence in colorectal cancer.
    Prévostel C; Blache P
    Eur J Cancer; 2017 Nov; 86():150-157. PubMed ID: 28988015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of SOX9 indicates a better prognosis and inhibits the growth of glioma cells by inducing cell cycle arrest.
    Gao J; Zhang JY; Li YH; Ren F
    Int J Clin Exp Pathol; 2015; 8(9):10130-8. PubMed ID: 26617720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXK2 suppresses the malignant phenotype and induces apoptosis through inhibition of EGFR in clear-cell renal cell carcinoma.
    Zhang F; Ma X; Li H; Zhang Y; Li X; Chen L; Guo G; Gao Y; Gu L; Xie Y; Duan J; Zhang X
    Int J Cancer; 2018 Jun; 142(12):2543-2557. PubMed ID: 29368368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of FOXK2 at Thr13 and Ser30 by PDK2 sustains glycolysis through a positive feedback manner in ovarian cancer.
    Zhang C; Xu Y; Zhu X; Zhang X; Wang F; Hu L; Lu H; Tao C; Xu K; Zhang Z; Li D; Shi T; Zhang R
    Oncogene; 2024 Jun; 43(26):1985-1999. PubMed ID: 38734828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Enhancer-Driven Stem Cell-Like Program Mediated by SOX9 Blocks Intestinal Differentiation in Colorectal Cancer.
    Liang X; Duronio GN; Yang Y; Bala P; Hebbar P; Spisak S; Sahgal P; Singh H; Zhang Y; Xie Y; Cejas P; Long HW; Bass AJ; Sethi NS
    Gastroenterology; 2022 Jan; 162(1):209-222. PubMed ID: 34571027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of SOX9 expression in colorectal cancer.
    Lü B; Fang Y; Xu J; Wang L; Xu F; Xu E; Huang Q; Lai M
    Am J Clin Pathol; 2008 Dec; 130(6):897-904. PubMed ID: 19019766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma.
    Hong Y; Chen W; Du X; Ning H; Chen H; Shi R; Lin S; Xu R; Zhu J; Wu S; Zhou H
    Oncotarget; 2015 Oct; 6(31):31241-54. PubMed ID: 26384302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional up-regulation of Sox9 by NF-κB in endometrial carcinoma cells, modulating cell proliferation through alteration in the p14(ARF)/p53/p21(WAF1) pathway.
    Saegusa M; Hashimura M; Suzuki E; Yoshida T; Kuwata T
    Am J Pathol; 2012 Aug; 181(2):684-92. PubMed ID: 22698986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin.
    Carrasco-Garcia E; Lopez L; Aldaz P; Arevalo S; Aldaregia J; Egaña L; Bujanda L; Cheung M; Sampron N; Garcia I; Matheu A
    Sci Rep; 2016 Aug; 6():32350. PubMed ID: 27571710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis.
    Shan L; Zhou X; Liu X; Wang Y; Su D; Hou Y; Yu N; Yang C; Liu B; Gao J; Duan Y; Yang J; Li W; Liang J; Sun L; Chen K; Xuan C; Shi L; Wang Y; Shang Y
    Cancer Cell; 2016 Nov; 30(5):708-722. PubMed ID: 27773593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
    Richtig G; Aigelsreiter A; Schwarzenbacher D; Ress AL; Adiprasito JB; Stiegelbauer V; Hoefler G; Schauer S; Kiesslich T; Kornprat P; Winder T; Eisner F; Gerger A; Stoeger H; Stauber R; Lackner C; Pichler M
    PLoS One; 2017; 12(11):e0187814. PubMed ID: 29121666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of LASP-1, a novel SOX9 transcriptional target, in the progression of lung cancer.
    Shi J; Guo J; Li X
    Int J Oncol; 2018 Jan; 52(1):179-188. PubMed ID: 29138807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness.
    Raspaglio G; Petrillo M; Martinelli E; Li Puma DD; Mariani M; De Donato M; Filippetti F; Mozzetti S; Prislei S; Zannoni GF; Scambia G; Ferlini C
    Gene; 2014 Jun; 542(2):173-81. PubMed ID: 24661907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.